0000080255-24-000835.txt : 20240410
0000080255-24-000835.hdr.sgml : 20240410
20240410125849
ACCESSION NUMBER: 0000080255-24-000835
CONFORMED SUBMISSION TYPE: SC 13G/A
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240410
DATE AS OF CHANGE: 20240410
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Immuneering Corp
CENTRAL INDEX KEY: 0001790340
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-92766
BUSINESS ADDRESS:
STREET 1: 245 MAIN STREET, SECOND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-500-8080
MAIL ADDRESS:
STREET 1: 245 MAIN STREET, SECOND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: PRICE T ROWE ASSOCIATES INC /MD/
CENTRAL INDEX KEY: 0000080255
STANDARD INDUSTRIAL CLASSIFICATION: SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES [6200]
ORGANIZATION NAME: 02 Finance
IRS NUMBER: 520556948
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G/A
BUSINESS ADDRESS:
STREET 1: 100 EAST PRATT ST
CITY: BALTIMORE
STATE: MD
ZIP: 21202
BUSINESS PHONE: (410)345-2000
MAIL ADDRESS:
STREET 1: P.O. BOX 89000
CITY: BALTIMORE
STATE: MD
ZIP: 21289
SC 13G/A
1
imrx13gamar24.txt
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 4)
IMMUNEERING CORP - CLASS A
(Name of Issuer)
COMMON STOCK
(Title of Class of Securities)
45254E107
(CUSIP NUMBER)
March 31, 2024
(Date of Event which Requires Filing of Statement)
Check the appropriate box to designate the Rule pursuant to which this
Schedule is filed:
[x] Rule 13d - 1(b)
Rule 13d - 1(c)
Rule 13d - 1(d)
1. Name of Reporting Person
T. ROWE PRICE ASSOCIATES, INC.
52-0556948
2. Check the Appropriate Box if a Member of a Group
NOT APPLICABLE
3. SEC Use Only
4. Citizenship or Place of Organization
Maryland
Number of Shares Beneficially Owned by Each Reporting Person With
5. Sole Voting Power* 910,266
6. Shared Voting Power* 0
7. Sole Dispositive Power* 910,266
8. Shared Dispositive Power 0
9. Aggregate Amount Beneficially Owned by Each Reporting Person
910,266
10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares
NOT APPLICABLE
11. Percent of Class Represented by Amount in Row 9
3.1%
12. Type of Reporting Person
IA
*Any shares reported in Items 5 and 6 are also reported in Item 7.
Item 1(a) Name of Issuer:
IMMUNEERING CORP - CLASS A
Item 1(b) Address of Issuer's Principal Executive Offices:
245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MASSACHUSETTS 02142
Item 2(a) Name of Person(s) Filing:
(1) T. ROWE PRICE ASSOCIATES, INC. (Price Associates)
Item 2(b) Address of Principal Business Office:
100 E. Pratt Street, Baltimore, MD 21202
Item 2(c) Citizenship or Place of Organization:
(1) Maryland
Item 2(d) Title of Class of Securities: COMMON STOCK
Item 2(e) Cusip Number: 45254E107
Item 3: The person filing this Schedule 13G is an:
X Investment Adviser registered under Section 203 of the Investment
Advisers Act of 1940
Item 4: Reference is made to Items 5-11 on the preceding pages of this
Schedule 13G.
Item 5: Ownership of Five Percent or Less of a Class
This statement is being filed to report the fact that, as of the date
of this report, the reporting person(s) has (have) ceased to be the
beneficial owner of more than five percent of the class of securities.
Item 6: Ownership of More than Five Percent on Behalf of Another Person
(1) Price Associates does not serve as custodian
of the assets of any of its clients; accordingly, in each
instance only the client or the client's custodian or
trustee bank has the right to receive dividends paid with
respect to, and proceeds from the sale of, such securities.
The ultimate power to direct the receipt of dividends paid with
respect to, and the proceeds from the sale of, such securities, is
vested in the individual and institutional clients which
Price Associates serves as investment adviser.
Any and all discretionary authority which has been delegated to
Price Associates may be revoked
in whole or in part at any time.
Except as may be indicated if this is a joint filing with one of the
registered investment companies sponsored by
Price Associates which it also serves as
investment adviser ("T. Rowe Price Funds"), not more
than 5% of the class of such securities is owned by any one client
subject to the investment advice of Price Associates.
Item 7: Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company.
Not Applicable
Item 8: Identification and Classification of Members of the Group
Not Applicable
Item 9: Notice of Dissolution of Group
Not Applicable
Item 10: Certification
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the
ordinary course of business and were not acquired and are not
held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were
not acquired and are not held in connection with or as a participant
in any transaction having that purpose or effect.
T. Rowe Price Associates, Inc. hereby declares and affirms
that the filing of Schedule 13G shall not be construed as an admission
that Price Associates is the beneficial owner of the
securities referred to, which beneficial ownership is expressly
denied.
Signature.
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true,
complete and correct.
T. ROWE PRICE ASSOCIATES, INC.
Date: April 10, 2024
Signature: /s/ Armando Capasso
Name & Title: Armando Capasso, Vice President
03/31/2024